Global Footprint Zambon operates across Europe, the Americas and Asia with multiple manufacturing sites and a broad product pipeline spanning respiratory, urological, and serious diseases, creating opportunities for multi-market sales, co-development, and regional regulatory partnerships.

Open Innovation The group actively cultivates biotech and startup collaborations through Zambon Biotech, Zcube and an Open Accelerator program focused on innovative therapies and femtech, signaling strong potential for licensing, co-development, or early-stage clinical partnerships.

Digital Supply Chain Zambon has invested in supply chain orchestration and analytics, including partnerships for end-to-end visibility; opportunities exist to augment with predictive demand forecasting, supplier risk management, serialization, and BI-integrated workflows to accelerate time-to-market across regions.

Patient Engagement The group operates patient support initiatives through ItaliAssistenza and PSP programs, presenting opportunities to offer digital patient engagement, home-care solutions, remote monitoring, adherence optimization, and payer-aligned support services.

Market Expansion Recent regulatory approvals and international launches demonstrate a path to new markets; opportunities exist to provide regulatory affairs support, market access strategy, pricing and reimbursement analytics, and localized commercialization services to accelerate launches.